HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam Buys 5,000 Shares theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 23,200 shares, a drop of 13.4% from the July 15th total of 26,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]
HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Update etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 24,300 shares, a growth of 86.9% from the May 31st total of 13,000 shares. Currently, 0.1% of the company’s shares are short sold. Based […]
HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 24,300 shares, an increase of 86.9% from the May 31st total of 13,000 shares. Based on an average daily trading volume, of 19,500 shares, […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) saw a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 13,000 shares, a decline of 13.3% from the May 15th total of 15,000 shares. Based on an average daily volume of 19,500 shares, the short-interest ratio is […]
HCW Biologics (HCWB) Granted Third US Patent for Methods of Treating Age-Related Disorders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HCW Biologics Inc. (NASDAQ: HCWB) saw its shares move up the chain Wednesday. The company a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, .
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) CFO Rebecca Byam acquired 20,000 shares of the stock in a transaction on Monday, June 5th. The stock was bought at an average price of $1.67 per share, for a total transaction of $33,400.00. Following the transaction, the chief financial officer now owns 480,188 shares in the company, […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) CFO Rebecca Byam purchased 20,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was bought at an average price of $2.03 per share, with a total value of $40,600.00. Following the acquisition, the chief financial officer now directly owns 519,250 shares in […]